Another target over expressed in solid GI malignancies is the human carcinoembryonic antigen (CEA), a cell surface glycoprotein, commonly used as a serum marker for colorectal and pancreatic cancers [85]. Here, CEACAM5 is linked to pancreatic neoplasm.